ANVISA’s approval for HN019™ to bolster Brazil probiotics market

In what may seem to be a major triumph for DuPont Nutrition & Health in probiotics market, the company has announced that it has obtained sanction from the Brazilian Health Regulatory Agency (ANVISA). The approval has been given for a health claim for the Bifidobacterium lactis HN019™ probiotic strain.

Post this sanction, Brazilian producers of probiotic foods and dietary supplements can now bring new products in the market faster using the DuPont probiotic to qualify for a health claim.

The sanctioned health claim is a powerful recognition for DuPont and also for the mechanism behind the Bifidobacterium lactis HN019™ probiotic strain. The approval will mean that food and supplement product packaging can now display the claim that Bifidobacterium lactis HN019™ contributes to gastrointestinal health.

Carolina Zago, Regulatory Affairs South America, DuPont, has been reported to say that the health authority has carefully considered the positive health effects of HN019™ during the evaluation process, also taking in account DuPont’s recognition in probiotics market as a reliable product supplier. She added that the approval will profit DuPont customers as well who can now speed up the process of bringing their products to the market.

The positive effects of HN019™ have been tested via numerous clinical and in-vitro studies. Two dietary intervention studies documented that even at low doses HN019™ can favorably modulate the composition of gut microbiota.

Daniel Borges, DuPont Nutrition & Health dietary supplements sales manager said that the gastrointestinal system is the human body’s greatest contact point with the environment and therefore it should be better protected from pathogens. By approving the health claim of HN019™, ANVISA has recognized its positive effect of helping to maintain the gut ecosystem balance.

Megan DeStefano, Probiotics global marketing manager for DuPont said that the success DuPont has achieved in Brazil follows its success in achieving recognition for Bifidobacterium lactis HN019™ probiotic stain in Switzerland and Japan. In both the countries, HN019™ has apparently been noted as a probiotic supporting digestion and improving bowel functioning in those suffering from constipation.